Shibayama, Osamu
Yoshiuchi, Kazuhiro
Inagaki, Masatoshi
Matsuoka, Yutaka
Yoshikawa, Eisho
Sugawara, Yuriko
Akechi, Tatsuo
Wada, Noriaki
Imoto, Shigeru
Murakami, Koji
Ogawa, Asao
Uchitomi, Yosuke
Article History
Received: 10 January 2018
Accepted: 1 August 2018
First Online: 30 August 2018
Compliance with ethical standards
:
: Author Uchitomi Y. received research grants from the Japanese Ministry of Health, Labour and Welfare for the submitted work. Author Inagaki M. declares that he has received grants from The Ministry of Health, Labour and Welfare, Japan, the Ministry of Education, Science, and Technology, Japan, Novartis Pharma, and Okayama Health Foundation. Author Inagaki M. received lecture fees from Pfizer Japan Inc., Mochida Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Daiichi-Sankyo Co., Ltd., Meiji Seika Pharma Co. Ltd., and Takeda Pharmaceutical Co., Ltd. outside the submitted work. Author Inagaki M. received royalties from Nippon Hyoron Sha Co., Ltd., Nanzando Co., Ltd., Seiwa Shoten Co., Ltd., Igaku-shoin Ltd., and Technomics, Inc., outside the submitted work. Author Matsuoka Y. received lecture fees from Morinaga Milk Industry Co. Ltd., Eli Lilly Japan K. K., and Takeda Pharmaceutical Company Ltd.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.